Amneal Pharmaceuticals, Inc.
AMRX
$6.98
$0.010.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.08M | -156.00K | 5.99M | -91.64M | -98.65M |
| Total Depreciation and Amortization | 66.13M | 58.96M | 55.57M | 55.53M | 56.93M |
| Total Amortization of Deferred Charges | 26.44M | 1.44M | 933.00K | 288.00K | 4.66M |
| Total Other Non-Cash Items | 34.74M | 38.76M | 33.88M | 43.39M | 119.18M |
| Change in Net Operating Assets | 21.86M | 42.77M | -56.72M | -11.97M | 53.70M |
| Cash from Operations | 118.08M | 141.77M | 39.66M | -4.41M | 135.82M |
| Capital Expenditure | -22.46M | -17.11M | -10.70M | -10.06M | -11.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 7.01M | 0.00 | 4.99M | -- | -- |
| Other Investing Activities | -600.00K | -3.60M | -750.00K | -9.70M | -19.90M |
| Cash from Investing | -16.06M | -20.71M | -6.47M | -19.76M | -31.69M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 48.00M | 326.73M |
| Total Debt Repaid | -55.54M | -87.21M | -27.00M | -63.38M | -262.57M |
| Issuance of Common Stock | 151.00K | 617.00K | 358.00K | 28.00K | 43.00K |
| Repurchase of Common Stock | -387.00K | -194.00K | -159.00K | -7.21M | -156.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.43M | -5.56M | -8.29M | -594.00K | -164.88M |
| Cash from Financing | -61.20M | -92.35M | -35.09M | -23.16M | -100.83M |
| Foreign Exchange rate Adjustments | -740.00K | 7.00K | -101.00K | -165.00K | 201.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.08M | 28.72M | -2.00M | -47.49M | 3.50M |
